Your browser doesn't support javascript.
loading
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
Gradishar, William J; Anderson, Benjamin O; Abraham, Jame; Aft, Rebecca; Agnese, Doreen; Allison, Kimberly H; Blair, Sarah L; Burstein, Harold J; Dang, Chau; Elias, Anthony D; Giordano, Sharon H; Goetz, Matthew P; Goldstein, Lori J; Isakoff, Steven J; Krishnamurthy, Jairam; Lyons, Janice; Marcom, P Kelly; Matro, Jennifer; Mayer, Ingrid A; Moran, Meena S; Mortimer, Joanne; O'Regan, Ruth M; Patel, Sameer A; Pierce, Lori J; Rugo, Hope S; Sitapati, Amy; Smith, Karen Lisa; Smith, Mary Lou; Soliman, Hatem; Stringer-Reasor, Erica M; Telli, Melinda L; Ward, John H; Young, Jessica S; Burns, Jennifer L; Kumar, Rashmi.
Affiliation
  • Gradishar WJ; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Anderson BO; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.
  • Abraham J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Aft R; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
  • Agnese D; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Allison KH; Stanford Cancer Institute.
  • Blair SL; UC San Diego Moores Cancer Center.
  • Burstein HJ; Dana-Farber/Brigham and Women's Cancer Center.
  • Dang C; Memorial Sloan Kettering Cancer Center.
  • Elias AD; University of Colorado Cancer Center.
  • Giordano SH; The University of Texas MD Anderson Cancer Center.
  • Goetz MP; Mayo Clinic Cancer Center.
  • Goldstein LJ; Fox Chase Cancer Center.
  • Isakoff SJ; Massachusetts General Hospital Cancer Center.
  • Krishnamurthy J; Fred & Pamela Buffet Cancer Center.
  • Lyons J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Marcom PK; Duke Cancer Institute.
  • Matro J; Abramson Cancer Center at the University of Pennsylvania.
  • Mayer IA; Vanderbilt-Ingram Cancer Center.
  • Moran MS; Yale Cancer Center/Smilow Cancer Hospital.
  • Mortimer J; City of Hope National Medical Center.
  • O'Regan RM; University of Wisconsin Carbone Cancer Center.
  • Patel SA; Fox Chase Cancer Center.
  • Pierce LJ; University of Michigan Rogel Cancer Center.
  • Rugo HS; UCSF Helen Diller Family Comprehensive Cancer Center.
  • Sitapati A; UC San Diego Moores Cancer Center.
  • Smith KL; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Smith ML; Research Advocacy Network.
  • Soliman H; Moffitt Cancer Center.
  • Stringer-Reasor EM; O'Neal Comprehensive Cancer Center at UAB.
  • Telli ML; Stanford Cancer Institute.
  • Ward JH; Huntsman Cancer Institute at the University of Utah.
  • Young JS; Roswell Park Comprehensive Cancer Center; and.
  • Burns JL; National Comprehensive Cancer Network.
  • Kumar R; National Comprehensive Cancer Network.
J Natl Compr Canc Netw ; 18(4): 452-478, 2020 04.
Article in En | MEDLINE | ID: mdl-32259783
ABSTRACT
Several new systemic therapy options have become available for patients with metastatic breast cancer, which have led to improvements in survival. In addition to patient and clinical factors, the treatment selection primarily depends on the tumor biology (hormone-receptor status and HER2-status). The NCCN Guidelines specific to the workup and treatment of patients with recurrent/stage IV breast cancer are discussed in this article.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Etiology_studies / Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: J Natl Compr Canc Netw Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Etiology_studies / Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: J Natl Compr Canc Netw Year: 2020 Document type: Article